Brawn Biotech

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue6.310.357.292.922.84
Expenses6.350.097.463.343.45
EBITDA-0.010.27-0.15-0.39-0.58
EBIT-0.040.27-0.17-0.42-0.61
Profit Before Tax-0.040.27-0.17-0.42-0.61
Net Profit-0.040.23-0.17-0.42-0.61
Financial Ratios
Operating Profit Margin-0.16%225.00%-2.19%-13.36%-20.42%
Net Profit Margin-0.63%191.67%-2.33%-14.38%-21.48%
Earning Per Share (Diluted)-0.180.47-0.58-1.43-2.02
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ